Vaccine Maker Gets Upgrade

Oppenheimer analyst moves stock to "outperform" on belief that Covid-19 demand has bottomed out.aker Gets Upgrade [Trade of the Day Wake-Up Watchlist] Good Morning Wake-Up Watchlisters! While you’re sipping coffee you’ll see stock futures fell on Wednesday after fresh jobs data caused optimism for interest-rate cuts to dip. Hopes that the year-end market rally would roll into 2024 hit a snag as indexes closed to their worst start in decades. Overall, the JOLTS report on job openings will set the fed’s expectations for the labor market and for the December monthly jobs report on Friday. Despite the volatile 2024 start in the markets, we were on fire on [The War Room]( yesterday. Our Lead Fundamental Tactician Karim Rahemtulla closed 12 winning trades, including 38% gain on TEVA in 433 trading days. [Click here to join The War Room and learn our top strategies for consistent winning trades in any market.]( Here’s a look at the top-moving stocks this morning. Moderna, Inc. (Nasdaq: MRNA) Moderna is up 1.70% in premarket trading after the vaccine maker received an upgrade from Oppenheimer & Co Analyst Hartaj Singh. Singh upgraded shares to “outperform,” with a price target of $142 per share. Singh based his upgrade on the idea that Covid-19 demand is bottoming and that means new material catalysts are coming to fund the pipeline. Rivian Automotive, Inc. (Nasdaq: RIVN) Rivian is down 1.94% premarket after the electric vehicle company fell short on deliveries in its latest data release. The EV maker said it produced 17,541 units and delivered 13,972 vehicles in the fourth quarter. Analysts had predicted fourth-quarter vehicle deliveries growing 75% to 14,000. Our Lead Technical Tactician Nate Bear is focusing on another top EV company in [Daily Profits Live]( this week. [Click here to unlock his latest trade.]( [It's Called "the Singularity"]( A new indicator shows "the Singularity" could launch as soon as three months from now. This is the moment we've all feared, when artificial intelligence officially surpasses human intelligence. And when the Singularity hits, the entire world will be thrown into chaos. [Click here to learn how to prepare yourself for what's to come.]( Longboard Pharmaceuticals (Nasdaq: LBPH) Longboard Pharmaceuticals is up 3.47% premarket after the company announced promising test results for a seizure treatment on Tuesday. In a study called Pacific, patients who received Longboard’s drug had 32.5% fewer seizures than placebo recipients. This put the biotech stock at its highest-ever point. Advanced Micro Devices (Nasdaq: AMD) Advanced Micro Devices is down 2.09% in premarket trading and fell 6% overall yesterday. The stock dropped on the news that ASML (the world's leading manufacturer in chip-making equipment) had paused shipments of its lithography machines for semiconductor fabrication to China. ASML’s decision reportedly stemmed from pressure applied by the U.S. government. Those are the biggest stock movers for today. Happy trading! The Wake-Up Watchlist Research Team [Dems PISSED?! (This Could Ruin the Green New Deal)]( [Alexandria Ocasio-Cortez]( A nuclear breakthrough is taking the world by storm... One company just signed an energy deal with the U.K. for $5 billion in annual revenue through 2050 (and 40,000 jobs)... And that's just the beginning. A February announcement could 10X this $3 stock over five years. [Get In NOW (Before You Lose Your Chance!)]( [Monument Traders Alliance] Monument Traders Alliance You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, [click here](. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 [Website]( | [Privacy Policy]( Keep the emails you value from falling into your spam folder. [Whitelist Trade of the Day](. © 2024 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.